Herbalife [HLF] vs John B. Sanfilippo [JBSS] Detailed Stock Comparison
Herbalife
NYSE
Loading...
John B. Sanfilippo
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Herbalife wins in 15 metrics, John B. Sanfilippo wins in 4 metrics, with 0 ties. Herbalife appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Herbalife | John B. Sanfilippo | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 2.80 | 13.33 | Herbalife |
| Price-to-Book Ratio | -1.41 | 2.11 | Herbalife |
| Debt-to-Equity Ratio | -3.58 | 36.62 | Herbalife |
| PEG Ratio | 4.47 | 13.22 | Herbalife |
| EV/EBITDA | 4.75 | 8.38 | Herbalife |
| Profit Margin (TTM) | 6.59% | 5.00% | Herbalife |
| Operating Margin (TTM) | 10.59% | 10.42% | Herbalife |
| EBITDA Margin (TTM) | 10.59% | 10.42% | Herbalife |
| Return on Equity | -31.74% | 16.58% | John B. Sanfilippo |
| Return on Assets (TTM) | 11.72% | 8.88% | Herbalife |
| Free Cash Flow (TTM) | $163.40M | $73.36M | Herbalife |
| Dividend Yield | N/A | 5.32% | N/A |
| 1-Year Return | 7.22% | -37.95% | Herbalife |
| Price-to-Sales Ratio (TTM) | 0.19 | 0.66 | Herbalife |
| Enterprise Value | $2.95B | $865.39M | Herbalife |
| EV/Revenue Ratio | 0.60 | 0.78 | Herbalife |
| Gross Profit Margin (TTM) | 78.01% | 21.42% | Herbalife |
| Revenue per Share (TTM) | $48 | $95 | John B. Sanfilippo |
| Earnings per Share (Diluted) | $3.18 | $4.72 | John B. Sanfilippo |
| Beta (Stock Volatility) | 0.86 | 0.35 | John B. Sanfilippo |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Herbalife vs John B. Sanfilippo Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Herbalife | 2.81% | -3.17% | -5.66% | 29.75% | 79.26% | 37.13% |
| John B. Sanfilippo | 1.98% | 0.03% | -5.13% | 1.05% | -11.14% | -27.26% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Herbalife | 7.22% | -70.28% | -82.17% | -68.64% | -35.71% | 19.76% |
| John B. Sanfilippo | -37.95% | -15.18% | -25.34% | 27.12% | 401.94% | 178.73% |
Performance & Financial Health Analysis: Herbalife vs John B. Sanfilippo
| Metric | HLF | JBSS |
|---|---|---|
| Market Information | ||
| Market Cap | $917.64M | $732.33M |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 2,128,650 | 67,520 |
| 90 Day Avg. Volume | 2,051,860 | 83,350 |
| Last Close | $9.16 | $63.47 |
| 52 Week Range | $5.04 - $10.83 | $58.47 - $102.18 |
| % from 52W High | -15.42% | -37.88% |
| All-Time High | $61.77 (Feb 04, 2019) | $127.26 (Jun 19, 2023) |
| % from All-Time High | -85.17% | -50.13% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.02% | -0.04% |
| Quarterly Earnings Growth | 9.49% | 0.50% |
| Financial Health | ||
| Profit Margin (TTM) | 0.07% | 0.05% |
| Operating Margin (TTM) | 0.11% | 0.10% |
| Return on Equity (TTM) | -0.32% | 0.17% |
| Debt to Equity (MRQ) | -3.58 | 36.62 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $-6.41 | $29.78 |
| Cash per Share (MRQ) | $3.11 | $0.11 |
| Operating Cash Flow (TTM) | $265.30M | $29.25M |
| Levered Free Cash Flow (TTM) | $274.58M | $-24,891,250 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 5.32% |
| Last 12-Month Dividend | $0.00 | $3.60 |
Valuation & Enterprise Metrics Analysis: Herbalife vs John B. Sanfilippo
| Metric | HLF | JBSS |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 2.80 | 13.33 |
| Forward P/E | 4.47 | 13.22 |
| PEG Ratio | 4.47 | 13.22 |
| Price to Sales (TTM) | 0.19 | 0.66 |
| Price to Book (MRQ) | -1.41 | 2.11 |
| Market Capitalization | ||
| Market Capitalization | $917.64M | $732.33M |
| Enterprise Value | $2.95B | $865.39M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.60 | 0.78 |
| Enterprise to EBITDA | 4.75 | 8.38 |
| Risk & Other Metrics | ||
| Beta | 0.86 | 0.35 |
| Book Value per Share (MRQ) | $-6.41 | $29.78 |
Financial Statements Comparison: Herbalife vs John B. Sanfilippo
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | HLF | JBSS |
|---|---|---|
| Revenue/Sales | $1.26B | $260.91M |
| Cost of Goods Sold | $276.90M | $205.01M |
| Gross Profit | $982.20M | $55.89M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $132.60M | $27.56M |
| EBITDA | $164.90M | $35.10M |
| Pre-Tax Income | $79.00M | $26.14M |
| Income Tax | $29.80M | $5.99M |
| Net Income (Profit) | $49.20M | $20.15M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | HLF | JBSS |
|---|---|---|
| Cash & Equivalents | $329.40M | $1.30M |
| Total Current Assets | $1.09B | $349.20M |
| Total Current Liabilities | $1.13B | $173.99M |
| Long-Term Debt | $2.14B | $31.07M |
| Total Shareholders Equity | $-736.00M | $346.61M |
| Retained Earnings | $-757.60M | $207.97M |
| Property, Plant & Equipment | $633.90M | $28.87M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | HLF | JBSS |
|---|---|---|
| Operating Cash Flow | $-10.30M | $-25.99M |
| Capital Expenditures | $-18.30M | $-11.68M |
| Free Cash Flow | $-18.10M | $-37.58M |
| Debt Repayment | $-70.30M | $-248,000 |
| Common Stock Repurchase | $-2.20M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | HLF | JBSS |
|---|---|---|
| Shares Short | 13.19M | 201,211 |
| Short Ratio | 7.28 | 2.19 |
| Short % of Float | 0.15% | 0.03% |
| Average Daily Volume (10 Day) | 2,128,650 | 67,520 |
| Average Daily Volume (90 Day) | 2,051,860 | 83,350 |
| Shares Outstanding | 101.20M | 11.60M |
| Float Shares | 86.00M | 9.01M |
| % Held by Insiders | 0.02% | 0.02% |
| % Held by Institutions | 1.04% | 0.93% |
Dividend Analysis & Yield Comparison: Herbalife vs John B. Sanfilippo
| Metric | HLF | JBSS |
|---|---|---|
| Last 12-Month Dividend | $0.00 | $3.60 |
| Last 12-Month Dividend Yield | N/A | 5.32% |
| 3-Year Avg Annual Dividend | $0.00 | $3.78 |
| 3-Year Avg Dividend Yield | N/A | 1.87% |
| 3-Year Total Dividends | $0.00 | $11.35 |
| Ex-Dividend Date | N/A | Aug 19, 2025 |